RSS-Feed abonnieren
DOI: 10.1055/s-2004-836054
Application of the Radical Cascade of Acyclic Peptide-Based Precursors into Analogues of Type I β-Turn
Publikationsverlauf
Publikationsdatum:
02. Dezember 2004 (online)
![](https://www.thieme-connect.de/media/synlett/200501/lookinside/thumbnails/10.1055-s-2004-836054-1.jpg)
Abstract
Radical cyclizations of di-, tri- and tetrapeptides containing N-2-bromobenzyl,N-methyl-substituted alanine or aspartic acid lead in good yields to α,β-unsaturated γ-lactams. The overall cascade, relying on a hydrogen atom transfer-elimination strategy could serve as a way to incorporate a flat and rigid five-membered ring into the peptide framework.
Key words
domino reactions - peptides - protecting groups - radicals - ring constructions
-
1a
Creighton CJ.Zapf CW.Bu JH.Goodman M. Org. Lett. 1999, 1: 1407 -
1b
Euguchi M.Lee MS.Nakanishi H.Stasiak M.Lovell S.Kahn M. J. Am. Chem. Soc. 1999, 121: 12204 -
1c
Spaller MR.Burger MT.Fardis M.Bartlett PA. Curr. Opin. Chem. Biol. 1997, 1: 47 -
2a
Smith LR.Bartlett PA. Molecules Online 1998, 2: 58 -
2b
Rose GD.Gierasch LM.Smith JA. Adv. Protein Chem. 1985, 37: 1 - 3
Kahn M. Synlett 1993, 821 -
4a
Khalil EM.Ojala WH.Pradhan A.Nair VD.Gleason WB.Mishra RK.Johnson RL. J. Med. Chem. 1999, 42: 628 -
4b
Johannesson P.Lindeberg G.Tong W.Gogoll A.Karlén A.Hallberg A. J. Med. Chem. 1999, 42: 601 -
4c
Hirschmann R.Hynes J.Cichy-Knight MA.van Rijn RD.Sprengeler PA.Spoors PG.Shakespeare WC.Pietranico-Cole S.Barbosa J.Liu J.Yao W.Rohrer S.Smith AB. J. Mol. Chem. 1998, 41: 1382 -
4d
Fink BE.Kym PR.Katzenellenbogen JA. J. Am. Chem. Soc. 1998, 120: 4334 -
4e
Hanessian S.Huynh HK.Reddy GV.McNaughton-Smith G.Ernst B.Kolb HC.Magnani J.Sweeley C. Bioorg. Med. Chem. Lett. 1998, 8: 2803 -
4f
Hanessian S.McNaughton-Smith G.Lombart HG.Lubell WD. Tetrahedron 1997, 53: 12789 -
5a
Freidinger RM.Perlow DS.Veber DF. J. Org. Chem. 1982, 47: 104 -
5b
Freidinger RM.Perlow DS.Veber DF.Brooks JR.Saperstein R. Science 1980, 210: 656 -
6a
Genin MJ.Johnson RL. J. Am. Chem. Soc. 1992, 114: 8778 -
6b
Genin MJ.Ojala WH.Gleason WB.Johnson RL. J. Org. Chem. 1993, 58: 2334 -
6c
Hinds MG.Richards NGJ. J. Chem. Soc., Chem. Commun. 1988, 1447 -
6d
Hinds MG.Welsh JH.Brennand DM.Fisher J.Glennie MJ.Richards NGJ.Turner DL.Robinson JA. J. Med. Chem. 1991, 34: 1777 -
7a
Nagai U.Sato K.Nakamura R.Kato R. Tetrahedron 1993, 49: 3577 -
7b
Nagai U.Sato K. Tetrahedron Lett. 1985, 26: 647 -
8a
Kahn M.Wilke S.Chen B.Fujika K. J. Am. Chem. Soc. 1988, 110: 1638 -
8b
Kahn M.Wilke S.Chen B.Fujika K.Lee Y.-H.Johnson ME. J. Mol. Recognit. 1988, 1: 75 -
8c
Kahn M.Nakanishi H.Chrusciel RA.Fitzpatrick D.Johnson ME. J. Med. Chem. 1991, 34: 3395 -
8d
Olson GL.Voss ME.Hill DE.Kahn M.Madison VS.Cook CM. J. Am. Chem. Soc. 1990, 112: 323 -
8e
Kemp DS.McNamara P. Tetrahedron Lett. 1982, 23: 3761 -
8f
Kemp DS.Stites WE. Tetrahedron Lett. 1988, 29: 5057 - 9
Easton CJ. Chem. Rev. 1997, 97: 53 -
10a
Blakskjaer P.Pedersen L.Skrydstrup T. J. Chem. Soc., Perkin Trans. 1 2001, 910 -
10b
Renaud P.Giraud L. Synthesis 1996, 913 -
11a
Wyss C.Batra R.Lehmann C.Sauer S.Giese B. Angew. Chem., Int. Ed. Engl. 1996, 35: 2529 -
11b
Sauer S.Staehelin C.Wyss C.Giese B. Chimia 1997, 51: 23 -
11c
Sauer S.Schumacher A.Barbosa F.Giese B. Tetrahedron Lett. 1998, 39: 3685 -
11d
Rancourt J.Gorys V.Jolicoeur E. Tetrahedron Lett. 1998, 39: 5339 -
11e
Giese B.Wettstein P.Stahelin C.Barbosa F.Neuburger M.Zehnder M.Wessig P. Angew. Chem. Int. Ed. 1999, 38: 2586 -
11f
Giese B.Barbosa F.Stahelin C.Sauer S.Wettstein P.Wyss C. Pure Appl. Chem. 2000, 72: 1623 - 12
Andrukiewicz R.Loska R.Prisyahnyuk V.Staliñski K. J. Org. Chem. 2003, 68: 1552 -
13a
Curran DP.Xu J. J. Am. Chem. Soc. 1988, 110: 5900 -
13b
Curran DP.Yu H. Synthesis 1992, 123 -
13c
Curran DP.Xu J. J. Am. Chem. Soc. 1988, 118: 3142 - 14
Stork G.Sher PM. J. Am. Chem. Soc. 1986, 108: 303 -
15a
Goodall K.Parsons AF. Tetrahedron 1996, 52: 6739 -
15b
Ishibashi H.Matsukida H.Toyao A.Tamura O.Takeda Y. Synlett 2000, 1497 -
17a
Stork G.Mah R. Heterocycles 1989, 28: 723 -
17b
Curran DP.Tamine J. J. Org. Chem. 1991, 56: 2746 -
17c
Curran DP.Liu W.Chen CH.-T. J. Am. Chem. Soc. 1999, 121: 11012 - 18
Strub W.Roduner E.Fisher H. J. Phys. Chem. 1987, 91: 4379 - 19
Musa OM.Horner JH.Newcomb M. J. Org. Chem. 1999, 64: 1022
References
Spectroscopic data of compounds 8-12:
2-[2-(3,4-Dimethyl-2-oxo-2,5-dihydro-pyrrol-1-yl)acetylamino]propionic Acid
tert
-Butyl Ester (8): IR (film): 3297, 3065, 2979, 2923, 1738, 1667, 1544, 1457, 1226, 1152 cm-1. 1H NMR: δ = 6.55 (1 H, br d, J = 6.7 Hz), 4.46-4.39 (1 H, quintet, J = 7.2 Hz), 4.21-3.96 (2 H, AB system, J = 16.3 Hz), 3.94-3.81 (2 H, AB system, J = 18.2 Hz), 1.98 (3 H, s), 1.82 (3 H, d, J = 0.9 Hz), 1.45 (9 H, s), 1.36 (3 H, d, J = 7.2 Hz) ppm. 13C NMR: δ = 173.4, 171.8, 168.2, 147.4, 128.3, 82.0, 55.3, 48.7, 46.5, 27.9, 18.4, 13.1, 8.6 ppm. MS (ESI): m/z = 319 [M+ + Na]. HRMS (ESI):
m/z calcd for C15H24O4N2Na: 319.1628; found: 319.1644.
(3-
tert
-Butoxycarbonylmethyl-2-oxo-4-trimethylsilanyl-methyl-2,5-dihydropyrrol-1-yl)acetic Acid Methyl Ester (9): IR (film): 1736, 1687, 1456, 1368, 1327, 1251, 1214, 1148, 849 cm-1. 1H NMR: δ = 4.22 (2 H, s), 3.91 (2 H, s), 3.72 (3 H, s), 3.18 (2 H, s), 1.91 (2 H, s), 1.44 (9 H, s), 0.09 (9 H, s) ppm. 13C NMR: δ = 172.0, 170.0, 169.5, 153.5, 123.1, 80.9, 54.9, 52.1, 43.3, 30.7, 28.0, 20.1, -1.0 ppm. MS [LSIMS(+)]: m/z = 356 [M+ + H], 378 [M+ + Na]. HRMS [LSIMS(+)]: m/z calcd for C17H30O5NSi: 356.1893; found: 356.1905.
2-[2-(1-Methoxycarbonylmethyl-2-oxo-4-trimethyl-silanylmethyl-2,5-dihydro-1
H
-pyrrol-3-ylacetyl-amino]propionic Acid
tert
-Butyl Ester (10): IR (film): 3299, 3064, 1741, 1667, 1537, 1457, 1369, 1220, 1152 cm-1. 1H NMR: δ = 7.30 (1 H, m), 4.38-4.31 (1 H, quintet, J = 7.2 Hz), 4.29-4.19 (2 H, AB system, J = 17.8 Hz), 3.98 (2 H, s), 3.73 (3 H, s), 3.27 (2 H, s), 2.09 (3 H, s), 1.43 (9 H, s), 1.35-1.33 (3 H, d, J = 7.1 Hz) ppm. 13C NMR: δ = 172.6, 171.8, 169.5, 168.8, 128.8, 126.3, 81.6, 55.3, 52.2, 49.0, 43.5, 34.5, 27.9, 18.1, 13.3 ppm. MS (ESI): m/z = 377 [M+ + Na]. HRMS (ESI): m/z calcd for C17H26O6N2Na: 377.1683; found: 377.1697.
2-[2-(3-
tert
-Butoxycarbonylmethyl-4-methyl-2-oxo-2,5-dihydropyrrol-1-yl)acetylamino]propionic Acid Benzyl Ester (11): IR (film): 3297, 3066, 1734, 1670, 1541, 1457, 1326, 1151, 747 cm-1. 1H NMR: δ = 7.38-7.31 (5 H, m), 6.62-6.57 (1 H, br d, J = 7.5 Hz), 5.19-5.10 (2 H, AB system, J = 12.3 Hz), 4.63-4.57 (1 H, quintet, J = 7.3 Hz), 4.24-3.95 (2 H, AB system, J = 16.2 Hz), 3.97-3.85 (2 H, AB system, J = 18.7 Hz), 3.24 (2 H, s), 2.00 (3 H, s), 1.45 (9 H, s), 1.42-1.40 (3 H, d, J = 7.2 Hz) ppm. 13C NMR: δ = 172.4, 172.2, 169.3, 168.4, 151.2, 135.4, 128.6, 128.4, 128.1, 126.3, 81.2, 67.1, 55.5, 48.1, 46.6, 30.3, 28.0, 18.0, 13.5 ppm. MS [LSIMS(+)]: m/z = 431 [M+ + H], 453 [M+ + Na]. HRMS [LSIMS(+)]: m/z calcd for C23H31O6N2: 431.2182; found: 431.2189.
2-(2-{1-[(1-
tert
-Butoxycarbonylethylcarbamoyl)methyl]-4-methyl-2-oxo-2,5-dihydro-1
H
-pyrrol-3-yl}acetyl-amino)propionic Acid
tert
-Butyl Ester (12): IR (film): 3299, 3065, 1736, 1659, 1543, 1455, 1368, 1226, 1152 cm-1. 1H NMR: δ = 7.30 (1 H, br s), 6.59 (1 H, br s), 4.60-3.90 (6 H, m), 3.26 (2 H, s), 2.09 (3 H, s), 1.45 (9 H, s), 1.44 (9 H, s), 1.37 (3 H, d, J = 7.2 Hz), 1.34 (3 H, d, J = 7.3 Hz) ppm. 13C NMR: δ = 172.8, 171.9, 171.8, 168.6, 167.7, 152.0, 128.7, 81.5 (2×), 55.8, 48.9, 48.8, 46.4, 32.5, 27.9 (2×), 18.3, 18.4, 13.4 ppm. MS (ESI): m/z = 468 [M+ + H], 490 [M+ + Na]. HRMS (ESI): m/z calcd for C23H37O7N3Na: 490.2524; found: 490.2542.